$0.105
+0 (+0%)
At Close: Dec 16, 2024
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
07:02pm, Wednesday, 03'rd May 2023
NanoString Technologies (NSTG) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.86 per share a year ago.
NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
06:00am, Monday, 10'th Apr 2023
SEATTLE--(BUSINESS WIRE)--NanoString to report Q1 2023 operating results on May 3, 2023.
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
06:00am, Wednesday, 01'st Mar 2023
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is sch
NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Tuesday, 28'th Feb 2023
NanoString (NSTG) delivered earnings and revenue surprises of -55.74% and 3.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
06:00am, Thursday, 23'rd Feb 2023
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is sch
NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
06:00am, Tuesday, 14'th Feb 2023
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company w
NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference
06:00am, Thursday, 22'nd Dec 2022
SEATTLE--( BUSINESS WIRE )--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company's managemen
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
06:00am, Thursday, 10'th Nov 2022
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company manag
NanoString Technologies (NSTG) Reports Q3 Loss, Misses Revenue Estimates
06:56pm, Monday, 07'th Nov 2022
NanoString (NSTG) delivered earnings and revenue surprises of -71.74% and 16.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
NanoString to Release Third Quarter 2022 Operating Results and Host Conference Call on Monday, November 7, 2022
06:00am, Wednesday, 12'th Oct 2022
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company w
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
06:00am, Wednesday, 07'th Sep 2022
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company manag
NanoString Technologies, Inc.'s (NSTG) CEO Brad Gray on Q2 2022 Earnings Call Transcript
10:56pm, Saturday, 06'th Aug 2022
NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations Brad Gray - President and
NanoString Technologies (NSTG) Reports Q2 Loss, Lags Revenue Estimates
06:48pm, Thursday, 04'th Aug 2022
NanoString (NSTG) delivered earnings and revenue surprises of -37.10% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
06:00am, Thursday, 04'th Aug 2022
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company manag
Wall Street Analysts See a 172% Upside in NanoString (NSTG): Can the Stock Really Move This High?
11:39am, Thursday, 21'st Jul 2022
The consensus price target hints at a 171.7% upside potential for NanoString (NSTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estim
Sign In
Buy NSTG